DaVita Inc. today announced that, as of 5:00 PM, Eastern Standard Time, April 4, 2002 (the expiration date of the consent solicitation period), it had received the requisite consents from the holders of its 9.25% Senior Subordinated Notes due 2011 (CUSIP Nos. 23918KAB4 and 23918KAA6) to the proposed amendments to the indenture under which the notes were issued, as set forth in its Offer to Purchase and Consent Solicitation Statement, dated March 21, 2002.

Credit Suisse First Boston Corporation and Banc of America Securities LLC are acting as Dealer Managers in connection with the tender offer and consent solicitation. Persons with questions regarding the tender offer and consent solicitation should contact Credit Suisse First Boston Corporation's Liability Management Group, at either 212-538-8474 or 800-820-1653 or Banc of America Securities LLC at 704-388-9217 or 888-292-0070. Requests for documentation should be made to Georgeson Shareholder, the Information Agent, at 212-440-9800 or 866-800-0507.

DaVita is a leading provider of dialysis services in the United States for patients suffering from chronic kidney failure. DaVita owns and operates kidney dialysis centers and home peritoneal dialysis programs in 32 states, as well as Washington, D.C. It currently operates 493 outpatient dialysis facilities serving approximately 43,000 patients and also provides acute hemodialysis services to inpatients at approximately 270 hospitals.

MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X14970077

SOURCE: DaVita Inc.